| IMMUNIC INC. DL-,0001 |
| USA |
| Gesundheit |
| US4525EP1011 / A2PHD4 |
| 10VA (Frankfurt) / IMUX (NASDAQ) |
| FRA:10VA, ETR:10VA, 10VA:GR, NASDAQ:IMUX |
| - |
| https://www.immunic-thera.. |
|
Immunic Inc. is a late-stage biotechnology company developing a pipeline of selective oral immunology therapies for chronic inflammatory and autoimmune diseases, with a focus on neurologic and gastrointestinal conditions. Its lead program, vidofludim..
>Volltext.. |
| 153.21 Mio. EUR |
| -7.28 Mio. EUR |
| - |
| -94.36 Mio. EUR |
| -89.88 Mio. EUR |
| -5.2 EUR |
| 0.36 Mio. EUR |
| 160.85 Mio. EUR |
| - |
| 4.86 |
| - |
| -8.19% |
| - |
| - |
| - |
| - |
| IMMUNIC |
| 26.05.26 |